Sustained release of a water-soluble GP IIb/IIIa antagonist from copoly(DL-lactic/glycolic) acid microspheres

International Journal of Pharmaceutics

Volumn 146, Issue 2, 1997, Pages 147-157

  Takada, Shigeyuki ^a   Kurokawa, Tomofumi ^a   Miyazaki, Keiko ^a   Iwasa, Susumu ^a   Ogawa, Yasuaki ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

GP IIb IIIa antagonist; L Arginine; Microsphere; PLGA; Sustained release

Indexed keywords

4 (4 AMIDINOBENZOYLGLYCYL) 3 METHOXYCARBONYLMETHYL 2 OXO 1 PIPERAZINEACETIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; MICROSPHERE; POLYGLACTIN; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; DRUG DOSAGE FORM; DRUG RELEASE; EMULSION; EVAPORATION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION;

EID: 0031039365     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04780-1     Document Type: Article

References (20)

1. Bodmeier R. and McGinity J.W., The preparation and evaluation of drug-containing poly(DL-lactide) microspheres formed by the solvent evaporation method. Pharm. Res., 4 (1987) 465-471.
2. Cohen S., Yoshioka T., Lucarelli M., Hwang L.H. and Langer R., Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res., 8 (1991) 713-720.
3. Fong J.W., Nazareno J.P., Pearson J.E. and Maulding H.V., Evaluation of biodegradable microspheres prepared by a solvent evaporation process using sodium oleate as emulsifier. J. Control. Release, 3 (1986) 119-130.
4. Herrmann J. and Bodmeier R., The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W O/W solvent evaporation method. J. Control. Release, 36 (1995) 63-71.
5. Heya T., Okada H., Tanigawara Y., Ogawa Y. and Toguchi H., Effects of counteranion of TRH and loading amount on control of TRH release from copoly (DL-lactic/glycolic acid) microspheres prepared by an in-water drying method. Int. J. Pharm., 69 (1991) 69-75.
6. Jalil R. and Nixon J. R., Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsulation. 7 (1990) 297-325.
7. 1 and Argatroban. J. Pharmacol. Exp. Ther., 277 (1996) 502-510.
8. Kwong A.K., Chou S., Sun A.M., Sefton MV. and Goosen M.F.A., In vitro and in vivo release of insulin from poly(lactic acid) microbeads and pellets. J. Control. Release, 4 (1986) 47-62.
9. Makino K., Arakawa M. and Kondo T., Preparation and in vitro degradation properties of polylactide microcapsules. Chem. Pharm. Bull., 33 (1985) 1195-1201.
10. Okada H., Heya T., Ogawa Y. and Shimamoto T., One-month release injectable microspheres of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. J. Pharmacol. Exp. Ther., 244 (1988) 744-750.
11. Okada H., Doken Y., Ogawa Y. and Toguchi H., Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res., 11 (1994a) 1143-1147.
12. Okada H., Yamamoto M., Heya T., Inoue Y., Kamei S., Ogawa Y. and Toguchi H., Drug delivery using biodegradable microspheres. J. Control. Release, 28 (1994b) 121-129.
13. Ogawa Y., Yamamoto M., Takada S., Okada H. and Shimamoto T., Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer. Chem. Pharm. Bull., 36 (1988) 1502-1507.
14. Peerlinck K., Lepeleire I.D., Goldberg M., Farrell D., Barrett J., Hand E., Panebianco D., Deckmyn H., Vermylen J., and Arnout J., MK-383 (L-700,462). a selective nonpeptide platelet glycoprotein IIb-IIIa antagonist, is active in man. Circulation. 88 (1993) 1512-1517.
15. Sanders L.M., Kent J.S., McRae G.I., Vickery B.H., Tice T.R. and Lewis D.H., Controlled release of a luteinizing hormone-releasing hormone analogue from poly(dl-lactide-co-glycolide) microspheres. J. Pharm. Sci., 73 (1984) 1294-1297.
16. Sanders L.M., McRae G.I., Vitale K. and Kell B.A., Controlled delivery of an LHRH analogue from biodegradable injectable microspheres. J. Control. Ralease, 2 (1985) 187-195.
17. Sanders L., Burns R., Vitale K. and Hoffman P., Clinical performance of nafarelin controlled release injectable: Influence of formulation parameters on release kinetics and duration of efficacy. Proc. Int. Symp. Controlled Release of Bioactive Materials, 15 (1988) 62-63.
18. The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N. Engl. J. Med., 330 (1994) 956-961.
19. Uchida T., Yoshida K. and Goto S., Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel W/O/W emulsion solvent evaporation method. J. Microencapsulation, 13 (1996) 219-228.
20. Yoshioka T., Okada H. and Ogawa Y., Sustained release microcapsule for water soluble drug. US Patent No. USP 5271945 (1993).